Treanda FDA Approval History
FDA Approved: Yes (First approved March 20, 2008)
Brand name: Treanda
Generic name: bendamustine hydrochloride
Dosage form: Injection
Company: Cephalon, Inc.
Treatment for: Chronic Lymphocytic Leukemia, Non-Hodgkin's Lymphoma
Treanda (bendamustine) is a purine alkylator hybrid chemotherapy agent indicated for the treatment of patients with chronic lymphocytic leukemia (CLL) and relapsed indolent non-Hodgkin's lymphoma.
Development Timeline for Treanda
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.